196 related articles for article (PubMed ID: 29733445)
1. Effects of treatment with an angiotensin 2 receptor blocker and/or vitamin D3 on parathyroid hormone and aldosterone: A randomized, placebo-controlled trial.
Bislev LS; Langagergaard Rødbro L; Nørgaard Bech J; Bjerregaard Pedersen E; Rolighed L; Sikjaer T; Rejnmark L
Clin Endocrinol (Oxf); 2018 Nov; 89(5):656-666. PubMed ID: 29733445
[TBL] [Abstract][Full Text] [Related]
2. The effect of vitamin D3 supplementation on markers of cardiovascular health in hyperparathyroid, vitamin D insufficient women: a randomized placebo-controlled trial.
Bislev LS; Langagergaard Rødbro L; Bech JN; Pedersen EB; Kjaergaard AD; Ladefoged SA; Rolighed L; Sikjaer T; Rejnmark L
Endocrine; 2018 Oct; 62(1):182-194. PubMed ID: 30043092
[TBL] [Abstract][Full Text] [Related]
3. Effect of isolated vitamin D supplementation on bone turnover markers in younger postmenopausal women: a randomized, double-blind, placebo-controlled trial.
Nahas-Neto J; Cangussu LM; Orsatti CL; Bueloni-Dias FN; Poloni PF; Schmitt EB; Nahas EAP
Osteoporos Int; 2018 May; 29(5):1125-1133. PubMed ID: 29450585
[TBL] [Abstract][Full Text] [Related]
4. Bone Microstructure in Response to Vitamin D3 Supplementation: A Randomized Placebo-Controlled Trial.
Bislev LS; Langagergaard Rødbro L; Rolighed L; Sikjaer T; Rejnmark L
Calcif Tissue Int; 2019 Feb; 104(2):160-170. PubMed ID: 30293198
[TBL] [Abstract][Full Text] [Related]
5. Cholecalciferol (vitamin D3) therapy and vitamin D insufficiency in patients with chronic kidney disease: a randomized controlled pilot study.
Chandra P; Binongo JN; Ziegler TR; Schlanger LE; Wang W; Someren JT; Tangpricha V
Endocr Pract; 2008; 14(1):10-7. PubMed ID: 18238736
[TBL] [Abstract][Full Text] [Related]
6. The effect of a single, large bolus of vitamin D in healthy adults over the winter and following year: a randomized, double-blind, placebo-controlled trial.
Kearns MD; Binongo JN; Watson D; Alvarez JA; Lodin D; Ziegler TR; Tangpricha V
Eur J Clin Nutr; 2015 Feb; 69(2):193-7. PubMed ID: 25271011
[TBL] [Abstract][Full Text] [Related]
7. Human interventions to characterize novel relationships between the renin-angiotensin-aldosterone system and parathyroid hormone.
Brown JM; Williams JS; Luther JM; Garg R; Garza AE; Pojoga LH; Ruan DT; Williams GH; Adler GK; Vaidya A
Hypertension; 2014 Feb; 63(2):273-80. PubMed ID: 24191286
[TBL] [Abstract][Full Text] [Related]
8. Aldosterone, parathyroid hormone, and the use of renin-angiotensin-aldosterone system inhibitors: the multi-ethnic study of atherosclerosis.
Brown J; de Boer IH; Robinson-Cohen C; Siscovick DS; Kestenbaum B; Allison M; Vaidya A
J Clin Endocrinol Metab; 2015 Feb; 100(2):490-9. PubMed ID: 25412416
[TBL] [Abstract][Full Text] [Related]
9. 1alpha(OH)D3 One-alpha-hydroxy-cholecalciferol--an active vitamin D analog. Clinical studies on prophylaxis and treatment of secondary hyperparathyroidism in uremic patients on chronic dialysis.
Brandi L
Dan Med Bull; 2008 Nov; 55(4):186-210. PubMed ID: 19232159
[TBL] [Abstract][Full Text] [Related]
10. Effect of vitamin D3 supplementation and influence of BsmI polymorphism of the VDR gene of the inflammatory profile and oxidative stress in elderly women with vitamin D insufficiency: Vitamin D3 megadose reduces inflammatory markers.
de Medeiros Cavalcante IG; Silva AS; Costa MJ; Persuhn DC; Issa CT; de Luna Freire TL; da Conceição Rodrigues Gonçalves M
Exp Gerontol; 2015 Jun; 66():10-6. PubMed ID: 25827670
[TBL] [Abstract][Full Text] [Related]
11. Plasma parathyroid hormone response to vitamin D3 supplementation among women of reproductive age: A randomized double-blind placebo-control trial.
Zan MCH; Ying MLE; Cheong LS; Lin KG
PLoS One; 2022; 17(11):e0276506. PubMed ID: 36356037
[TBL] [Abstract][Full Text] [Related]
12. Dose-response effects of supplementation with calcifediol on serum 25-hydroxyvitamin D status and its metabolites: A randomized controlled trial in older adults.
Vaes AMM; Tieland M; de Regt MF; Wittwer J; van Loon LJC; de Groot LCPGM
Clin Nutr; 2018 Jun; 37(3):808-814. PubMed ID: 28433267
[TBL] [Abstract][Full Text] [Related]
13. Effects of vitamin D3 supplementation for 12 weeks on serum levels of anabolic hormones, anaerobic power, and aerobic performance in active male subjects: A randomized, double-blind, placebo-controlled trial.
Ramezani Ahmadi A; Mohammadshahi M; Alizadeh A; Ahmadi Angali K; Jahanshahi A
Eur J Sport Sci; 2020 Nov; 20(10):1355-1367. PubMed ID: 31957555
[TBL] [Abstract][Full Text] [Related]
14. Influence of AT1 receptor blockade on blood pressure, renal haemodynamics and hormonal responses to intravenous angiotensin II infusion in hypertensive patients.
Fridman KU; Elmfeldt D; Wysocki M; Friberg PR; Andersson OK
Blood Press; 2002; 11(4):244-52. PubMed ID: 12361194
[TBL] [Abstract][Full Text] [Related]
15. The tolerability and biochemical effects of high-dose bolus vitamin D2 and D3 supplementation in patients with vitamin D insufficiency.
Leventis P; Kiely PD
Scand J Rheumatol; 2009; 38(2):149-53. PubMed ID: 18991184
[TBL] [Abstract][Full Text] [Related]
16. Interaction of Vitamin D with Peptide Hormones with Emphasis on Parathyroid Hormone, FGF23, and the Renin-Angiotensin-Aldosterone System.
Latic N; Erben RG
Nutrients; 2022 Dec; 14(23):. PubMed ID: 36501215
[TBL] [Abstract][Full Text] [Related]
17. Aldosterone and parathyroid hormone interactions as mediators of metabolic and cardiovascular disease.
Tomaschitz A; Ritz E; Pieske B; Rus-Machan J; Kienreich K; Verheyen N; Gaksch M; Grübler M; Fahrleitner-Pammer A; Mrak P; Toplak H; Kraigher-Krainer E; März W; Pilz S
Metabolism; 2014 Jan; 63(1):20-31. PubMed ID: 24095631
[TBL] [Abstract][Full Text] [Related]
18. Vitamin D supplementation in obese type 2 diabetes subjects in Ajman, UAE: a randomized controlled double-blinded clinical trial.
Sadiya A; Ahmed SM; Carlsson M; Tesfa Y; George M; Ali SH; Siddieg HH; Abusnana S
Eur J Clin Nutr; 2015 Jun; 69(6):707-11. PubMed ID: 25406966
[TBL] [Abstract][Full Text] [Related]
19. Effects of a short-term vitamin D(3) and calcium supplementation on blood pressure and parathyroid hormone levels in elderly women.
Pfeifer M; Begerow B; Minne HW; Nachtigall D; Hansen C
J Clin Endocrinol Metab; 2001 Apr; 86(4):1633-7. PubMed ID: 11297596
[TBL] [Abstract][Full Text] [Related]
20. A high aldosterone to renin ratio is associated with high serum parathyroid hormone concentrations in the general population.
Fischer E; Hannemann A; Rettig R; Lieb W; Nauck M; Pallauf A; Bidlingmaier M; Beuschlein F; Wallaschofski H; Reincke M
J Clin Endocrinol Metab; 2014 Mar; 99(3):965-71. PubMed ID: 24423297
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
